Replimune Group Stock

Replimune Group Liabilities 2024

Replimune Group Liabilities

113.21 M USD

Ticker

REPL

ISIN

US76029N1063

WKN

A2JQN1

In 2024, Replimune Group's total liabilities amounted to 113.21 M USD, a 126.43% difference from the 50 M USD total liabilities in the previous year.

Replimune Group Aktienanalyse

What does Replimune Group do?

Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Replimune Group's Liabilities

Replimune Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Replimune Group's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Replimune Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Replimune Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Replimune Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Replimune Group stock

What is the level of liabilities of Replimune Group this year?

Replimune Group has a debt balance of 113.21 M USD this year.

What were the liabilities of Replimune Group compared to the previous year?

The liabilities of Replimune Group have increased by 126.43% increased compared to the previous year.

What are the consequences of high debt for investors of Replimune Group?

High liabilities can pose a risk for investors of Replimune Group, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Replimune Group?

Low liabilities mean that Replimune Group has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Replimune Group affect the company?

An increase in liabilities of Replimune Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Replimune Group affect the company?

A decrease in the liabilities of Replimune Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Replimune Group?

Some factors that can influence the liabilities of Replimune Group include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Replimune Group so important for investors?

The liabilities of Replimune Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Replimune Group take to modify the liabilities?

To change its liabilities, Replimune Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Replimune Group pay?

Over the past 12 months, Replimune Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Replimune Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Replimune Group?

The current dividend yield of Replimune Group is .

When does Replimune Group pay dividends?

Replimune Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Replimune Group?

Replimune Group paid dividends every year for the past 0 years.

What is the dividend of Replimune Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Replimune Group located?

Replimune Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Replimune Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Replimune Group from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Replimune Group pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Replimune Group in the year 2023?

In the year 2023, Replimune Group distributed 0 USD as dividends.

In which currency does Replimune Group pay out the dividend?

The dividends of Replimune Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Replimune Group

Our stock analysis for Replimune Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Replimune Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.